Evidence map›Paper›PMID 33561169›Full record

ArticlePloS one2021

Birth weight, growth, nutritional status and mortality of infants from Lambaréné and Fougamou in Gabon in their first year of life.

Rella Zoleko-Manego, Johannes Mischlinger, Jean Claude Dejon-Agobé, Arti Basra, J Rodolphe Mackanga, Daisy Akerey Diop, Ayola Akim Adegnika, Selidji T Agnandji, Bertrand Lell, Peter G Kremsner and 5 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00811421 (Evaluation of the Safety and Efficacy of Mefloquine as Intermittent Preventive Treatment of Malaria in Pregnancy), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00811421 nacompletednot on this map

Evaluation of the Safety and Efficacy of Mefloquine as Intermittent Preventive Treatment of Malaria in Pregnancy

TypeinterventionalSponsorHospital Clinic of BarcelonaRan2009 to 2013Enrolled5,820ConditionsPregnancy, Malaria, HIV InfectionsArmsSulphadoxine-pyrimethamine, Mefloquine (full dose), Mefloquine (split dose), placebo, mefloquine
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Avoidable mortality in childhood in Colombia: A type of violenceBiomedica : revista del Instituto Nacional de Salud · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Journal of public health in Africa · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 5 countries.

Rella Zoleko-ManegoCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.ORCID 0000-0001-7425-2794
Johannes MischlingerDepartment of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Jean Claude Dejon-AgobéCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.ORCID 0000-0003-3816-998X
Arti BasraCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
J Rodolphe MackangaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Daisy Akerey DiopCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Ayola Akim AdegnikaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Selidji T AgnandjiCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Bertrand LellCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Peter G KremsnerCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Pierre Blaise MatsieguiCentre de Recherches Médicales de la Ngounié (CRMN), Fougamou, Gabon.
Raquel GonzálezBarcelona Institute for Global Health, ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Clara MenendezBarcelona Institute for Global Health, ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Michael RamharterCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Ghyslain Mombo-NgomaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Centre de Recherche Médicales de Lambaréné · GAUniversität Hamburg · DEBarcelona Institute for Global Health · ESCentre International de Recherches Médicales de Franceville · GAUniversitat de Vic - Universitat Central de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalnutrition and low birth weight (LBW) are two common causes of morbidity and mortality among children in sub-Saharan Africa. Both malnutrition and LBW affect early childhood development with long term consequences that may vary in their degree depending on the geographical setting. This study evaluates growth, nutritional status and mortality of infants from Lambaréné and Fougamou in Gabon from a birth cohort of a malaria in pregnancy clinical trial (NCT00811421).

methodA prospective longitudinal birth cohort conducted between 2009 and 2012, included infants that were followed up from birth until their first-year anniversary. The exposure of interest was low birth weight and the outcomes explored were growth represented by weight gain, the nutritional status including stunting, wasting and underweight, and the mortality. Scheduled follow-up visits were at one, nine and 12 months of age. Logistic regression was used to assess the association between low birth weight and growth and nutritional outcomes, and cox regression was used for mortality.

resultA total of 907 live-born infants were included in the analysis. The prevalence of LBW was 13% (115). At one month of life, out of 743 infants 10% and 4% presented with stunting and underweight, respectively, while these proportions increased at 12 months of life to 17% and 21%, respectively, out of 530 infants. The proportion of infants with wasting remained constant at 7% throughout the follow-up period. Stunting and underweight were associated with LBW, adjusted odds ratio (aOR): 2.6, 95% confidence interval (95%CI): 1.4-4.9 and aOR: 4.5, 95%CI: 2.5-8.1, respectively. Preterm birth was associated with stunting, aOR: 2.7, 95%CI: 1.2-6.3 and underweight, aOR: 5.4, 95%CI: 1.7-16.1 at one month of life. Infants with LBW were at higher hazard of death during the first year of life, adjusted hazard ratio 4.6, 95%CI: 1.2-17.0.

conclusionLow birthweight infants in Gabon are at higher risks of growth and nutritional deficits and mortality during the first year of life. Tailored interventions aiming at preventing adverse pregnancy outcomes including LBW, early detection and appropriate management of growth, and nutritional deficits in infants are necessary in Gabon.

Indexed as

Birth WeightCase-Control StudiesFemaleGabonHumansInfantInfant, Low Birth WeightInfant MortalityInfant, NewbornLogistic ModelsLongitudinal StudiesMaleMalnutritionNutritional StatusNutrition AssessmentOdds Ratio

Identifiers

PMID33561169
PMCPMC7872243
OpenAlexW3128543613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.